Analysis of KRS 141.0205 and the Strategic Deferral of the Kentucky Research Facilities Tax Credit

I. Executive Summary: The KRS 141.0205 Mandate and R&D Credit Positioning

Kentucky Revised Statute (KRS) 141.0205 establishes a mandatory hierarchy for applying nonrefundable business tax credits against state income and Limited Liability Entity Tax (LLET) liabilities. This fixed order dictates that the Kentucky Qualified Research Facilities Tax Credit must be utilized only after several higher-priority credits have been exhausted, ensuring its value is often realized across multiple future tax periods.

This statutory mandate requires any taxpayer entitled to multiple credits against the taxes imposed by KRS 141.020 (Individual Income Tax), KRS 141.040 (Corporation Income Tax), and KRS 141.0401 (LLET) to follow a predefined, non-discretionary sequence.1 The Kentucky Qualified Research Facilities Tax Credit (KRS 141.395), which provides an incentive for capital investment in research infrastructure, is situated low in this sequence, specifically at subdivision (j) of KRS 141.0205(1).1 This low placement functions as a legislative mechanism to manage state revenue by prioritizing foundational compliance credits, such as the Limited Liability Entity Tax (LLET) credit, and other major economic development incentives. Since the Research Facilities Credit is typically generated in one large amount—5% of capital costs—its low priority placement forces the unused balance into its permissible 10-year carryforward window, turning it into a long-term asset rather than an immediate tax reduction.2

II. Statutory Foundation and Intent of KRS 141.0205

A. The Law Defined: Mandatory Ordering of Nonrefundable Credits

KRS 141.0205 is the controlling authority for the “Priority of application and use of tax credits” in Kentucky. This statute applies broadly to all nonrefundable business incentive credits claimed against the primary state taxes.1 The law’s structure is crucial: it requires a taxpayer to apply available credits in sequential order, from (a) through the final subdivision, using the maximum possible amount from each credit to reduce the remaining tax liability before moving to the next credit in the list.1

This non-discretionary sequence ensures standardized tax compliance, eliminating any opportunity for taxpayers to strategically sequence credits based on individual carryforward expiration dates or immediate cash flow needs. This rigidity provides the Kentucky Department of Revenue (DOR) with a predictable framework for revenue forecasting.5

B. Nonrefundability, Carryforward, and Expiration Risk

The strict ordering established by KRS 141.0205 is magnified by the nonrefundable nature of the credits it governs. The Research Facilities Credit (KRS 141.395) is, by definition, nonrefundable.2 This means the credit can only offset a tax liability and cannot generate a cash refund. If the tax liability is eliminated by credits ranked (a) through (i), the R&D credit amount is entirely deferred.

The Qualified Research Facilities Credit allows for a generous 10-year carryforward period for any unused credit balance.2 However, the low priority of the R&D credit, coupled with the state’s fiscal policy environment, increases the risk of expiration. Since the Kentucky General Assembly has recently focused on lowering the individual and corporate income tax rates (e.g., the reduction to 4% for 2024 income tax) 7, the total “tax pool” available for consumption by deferred credits is progressively shrinking. This contraction of the tax base, when combined with the low statutory ranking, makes the possibility of R&D credit expiration before full utilization a significant concern for long-term tax planning.

Furthermore, the statute requires continuous attention due to regular legislative activity. Each time a new, nonrefundable business credit is proposed or enacted (such as the suggested home modification tax credit or the employer’s organ donation tax credit) 8, KRS 141.0205 must be amended to assign it a rank. If new high-priority credits are inserted above the R&D credit at (j), they serve to further erode the tax base available for R&D utilization in future years.

III. The Kentucky Qualified Research Facility Tax Credit (KRS 141.395)

The credit defined by KRS 141.395 is the specific incentive often termed the Kentucky R&D tax credit, though its focus is distinct from the federal R&D tax credit.

A. Overview of the Kentucky R&D Incentive Structure

This nonrefundable credit is equal to five percent (5%) of qualified costs.2 Its application is broad, offsetting income tax imposed by KRS 141.020 (individual), KRS 141.040 (corporate), and the LLET imposed by KRS 141.0401.3

Qualified costs are defined narrowly, covering only capital investments: “constructing, remodeling, and equipping facilities in this state or expanding existing facilities in this state for qualified research”.3 The assets involved must be tangible, depreciable property and must not include replacement property.3 The definition of “qualified research” aligns with Section 41 of the Internal Revenue Code.3

Unused amounts are permitted to be carried forward for a period of ten (10) years.2

B. Strategic Positioning as a Capital Investment Incentive

The Kentucky R&D tax credit differs fundamentally from its federal counterpart (IRC Section 41). The federal credit primarily focuses on operational expenses, such as wages, supplies, and contract research (Qualified Research Expenses or QREs). In contrast, the Kentucky incentive explicitly targets capital investment in physical facilities.2

This distinction has profound implications for tax planning under KRS 141.0205. Because the credit is generated by a large, singular capital event (e.g., the construction of a new multi-million dollar facility), the resulting credit amount is often substantial relative to the taxpayer’s annual tax liability. The legislative placement of this large, one-time credit generation at position (j) effectively guarantees that the benefit will be deferred and stretched across the entire 10-year carryforward period. The state treats the incentive not as an immediate operational subsidy, but as a mechanism for long-term capital recovery, which requires taxpayers to discount the immediate value of the credit due to the time required for its realization.

IV. Deconstructing the Credit Ordering Hierarchy

The statutory ordering under KRS 141.0205 is the determinative factor for R&D credit realization. Taxpayers must exhaust credits ranked (a) through (i) before any amount of the Research Facilities Credit (j) can be applied.

A. Mandatory Preceding Credits

The Research Facilities Credit (KRS 141.395) is explicitly located at subdivision (j) of KRS 141.0205(1). This placement ensures that it is subordinate to many critical credits 1:

1. Limited Liability Entity Tax Credit (LLET): Positioned at (a), this is the highest-priority nonrefundable business incentive credit.1 The LLET credit is generated from the LLET obligation (based on gross receipts or assets), which is designed to ensure entities meet a minimum tax burden regardless of profitability. By placing the LLET credit first, the statute ensures that this fundamental obligation is offset against the income tax liability, serving as the primary mechanism for reducing the pool of available income tax liability for all subsequent, lower-ranked incentives. If a company’s income tax liability is similar in magnitude to its LLET credit, the LLET credit alone may consume most of the liability, forcing the R&D credit immediately into carryforward status.
2. Economic Development Credits: Positioned collectively at (b), this group includes various incentives computed under statutes such as KRS 141.347, 141.381, and others.1 These credits are typically related to job creation or investment programs. Although the DOR guidance indicates that credits within group (b) do not need to be used in any specific order, the entire collective group must be applied before the hierarchy proceeds to (c).10
3. Tax Paid to Other States Credit: Positioned at (f).1 This credit is vital for multi-state entities to prevent double taxation. Its high priority ensures that multi-state firms will substantially reduce their Kentucky tax liability here, further diminishing the tax base available for the R&D credit at (j).

The intentional separation and lower ranking of the Research Facilities Credit (j) from the main “Economic Development Credits” group (b) confirms the legislative intent to defer the realization of this capital investment benefit. The utilization of the R&D credit is constrained by the performance and application of at least nine preceding credit types.

V. Kentucky Department of Revenue (DOR) Guidance and Filing Requirements

The application of KRS 141.0205 is managed through specific forms mandated by the Kentucky Department of Revenue (DOR), ensuring taxpayers adhere to the mandatory sequence.

A. Operationalizing the Ordering: Required Schedules

Corporate taxpayers claiming the credit against Corporation Income Tax (KRS 141.040) or LLET (KRS 141.0401) must utilize Schedule TCS (Tax Credit Summary).5 The instructions for Schedule TCS explicitly reference KRS 141.0205 and mandate that credits be applied precisely in the order listed on the schedule.10

For individual taxpayers, including those receiving passthrough credits from a partnership or S corporation, the credits are claimed on Schedule ITC (Individual Tax Credit Summary).5 Passthrough entities (PTEs) pass the credit through to their partners, members, or shareholders via Kentucky Schedule K-1. The ultimate claimant must then apply the credit against their individual income tax liability following the strict hierarchy outlined in KRS 141.0205.4

B. Documentation and Long-Term Compliance for R&D Carryforwards

The Qualified Research Facility Tax Credit requires specific documentation due to its long carryforward period and low priority placement. Taxpayers must file Schedule QR (Qualified Research Facility Tax Credit) with their income tax return initially to determine the credit amount, and a copy of Schedule QR must be submitted each subsequent year until the full credit is used or the 10-year period expires.3

Furthermore, the DOR mandates that taxpayers attach a detailed supporting schedule listing all qualifying tangible, depreciable property, including purchase date, in-service date, description, and cost.3 This yearly requirement for submitting the supporting documentation and Schedule QR ensures that the DOR can consistently track the utilization and proper substantiation of the original capital investment claim throughout the decade-long carryforward period. This elevated administrative burden highlights the regulatory focus on ensuring the validity of deferred incentives that may span multiple audit cycles.

VI. Strategic Implications and Credit Optimization

The strategic valuation of the Research Facilities Credit must integrate the constraints imposed by KRS 141.0205. The utilization calculation transforms into a complex, multi-year linear constraint problem where the credit’s effective worth is dictated by the ability to generate sufficient residual Kentucky income tax liability.

A. Forecasting LLET Consumption

Effective modeling starts at the top of the priority list with the LLET Credit (a). Tax professionals must accurately forecast the LLET liability, as the resulting credit will be the most immediate and significant reducer of the income tax base. If the LLET credit is projected to consume most of the income tax liability, the Research Facilities Credit (j) is guaranteed to be deferred for the foreseeable future. The analysis must involve a sensitivity assessment of variables impacting LLET (e.g., changes in gross receipts) to accurately determine the annual residual tax capacity available for the R&D credit.

B. Managing the 10-Year Utilization Window

Because the realization of the R&D benefit is deliberately slow, proactive long-term planning is essential to mitigate the risk of expiration. The shrinking Kentucky income tax rates, referenced in recent legislative updates 7, further necessitate sophisticated 10-year projections of Kentucky Taxable Net Income. If forecasts indicate that the carryforward may expire unused, corporations must evaluate advanced tax mitigation strategies, such as reviewing internal apportionment methods (where legally permissible) or exploring options to accelerate Kentucky source taxable income.

C. Coordination Challenges for Passthrough Entities

When the credit is passed to individual owners, the subordination problem is often exacerbated. On the individual’s Schedule ITC, the R&D credit (j) must compete against the highly ranked Tax Paid to Other States Credit (f).1 Individuals often have substantial tax credits from other state obligations, which frequently consume the majority of their Kentucky income tax liability, immediately forcing the R&D credit into carryforward status on the individual’s return. Therefore, successful utilization requires strong coordination between the entity generating the large capital credit and its ultimate individual claimants to ensure annual tracking and compliance.

VII. Detailed Application Example: Navigating Concurrent Credits

This example demonstrates the mandatory sequencing of KRS 141.0205 and the resulting deferral of the Qualified Research Facilities Credit.

A. Scenario Setup: Taxpayer Data

A corporate taxpayer, Delta Research Corp., incurred $10 million in qualified research facility costs, generating a $500,000 credit (5% of costs) in the current tax year. The taxpayer also holds other high-priority nonrefundable credits.

Tax Year Data and Liabilities:

B. Step-by-Step Application of KRS 141.0205

The application must follow the mandated priority sequence to exhaust the $180,000 liability.

Table: Mandatory Application of Credits

C. Result and Deferral Conclusion

In this scenario, Delta Research Corp. applied $130,000 of higher-priority credits (LLET, Economic Development, and Other States) before the Research Facilities Credit was even reached. The remaining tax liability of $50,000 allowed only 10% of the $500,000 R&D credit to be utilized in the current year.

The result is a mandatory, non-negotiable $450,000 carryforward, which must be tracked and utilized over the next ten years. This outcome is a direct consequence of KRS 141.0205 placing the R&D incentive at position (j), subordinate to fundamental compliance and core economic incentives.

VIII. Conclusion and Forward Look

A. Synthesis of Constraints

KRS 141.0205 serves as a mandatory gatekeeper for all Kentucky nonrefundable business incentives. For the Qualified Research Facilities Tax Credit (KRS 141.395), its statutory position at subdivision (j) ensures that the large, capital-based credits are systematically deferred. The analysis confirms that the LLET Credit (a) and the Tax Paid to Other States Credit (f) are the primary constraints that push the Research Facilities Credit into a carryforward status. This structural reality requires sophisticated financial and tax planning that focuses on the long-term prediction of residual tax liability rather than on the immediate benefit of the 5% credit generation.

B. Compliance and Strategic Recommendations

1. Mandatory Compliance Tracking: Given the 10-year carryforward period, taxpayers must adhere strictly to the DOR’s requirements for annual filing of Schedule QR and the detailed supporting schedule of depreciable property.3 This ensures substantiation of the original claim and proper tracking of the utilized balance, which is critical for mitigating audit risk over the decade-long life of the credit.
2. Monitoring Legislative Risk: The constant legislative modification of KRS 141.0205 (such as the insertion of new credits) must be monitored closely, as the addition of any new credit above position (j) will directly diminish the future pool of tax liability available to consume the existing R&D carryforward.
3. Modeling the Shrinking Tax Base: Taxpayers must incorporate Kentucky’s ongoing income tax rate reduction trend into their utilization models. A lower income tax rate reduces the ceiling for tax liability reduction, increasing the probability of credit expiration. The realized value of the Research Facilities Credit is, therefore, discounted by both the time value of money and the increasing probability of non-utilization within the 10-year window.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/